Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

April 30, 2010

Study Completion Date

February 28, 2011

Conditions

NeuroblastomaSarcomaUnspecified Childhood Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL

anti-thymocyte globulin

DRUG

busulfan

DRUG

cyclosporine

DRUG

melphalan

DRUG

methotrexate

DRUG

methylprednisolone

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

PROCEDURE

umbilical cord blood transplantation

Trial Locations (1)

Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center, Hershey

All Listed Sponsors

lead

Milton S. Hershey Medical Center

OTHER

NCT00112645 - Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors | Biotech Hunter | Biotech Hunter